Class III Fast reaction rapid SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab 1 piece

Class III Fast reaction rapid SARS-CoV-2 Antigen Test Set Nasopharyngeal Swab 1 piece​

Description

Reliable, rapid chromatographic immunoassay for the qualitative detection of specific antigens of SARS-CoV-2 present in the human nasopharynx

Date sheet

Advantages of Antigen Rapid Test

Although the development cycle of antigen detection is relatively long, its
1.Sensitivity and specificity are higher than antibody detection
2.The pathogen can be detected at the initial stage of infection
3.Short TAT and simple operation.
4.No professional technicians and equipment are required, and the test can be completed in 15 min.
5.Home use.
6.Personal test.

Materials Provided

Interpretation Of Test Results

1. This set contains quality control process, when the pink/purple reaction line appears in the C zone, it indicates the correct and effective operation. C line is the prerequisites to see if the test is valid. If the C line does not show color, regardless of whether the T line shows color or not, the test is invalid, and it is recommended to retest.

2. The detection results ofthe set are interpreted according to the following table.

Jiangsu iiLO Biotechnology Co., Ltd. is located in Xukou Town, Wuzhong District, Suzhou City, Jiangsu Province. Suzhou is 100 kilometers away from Shanghai and 200 kilometers away from Nanjing. It is in the center of the Yangtze River Delta Economic Belt. Our main business covers two major sudivisions: BioScience and BioMedicine, including scientific instruments and life science reagents research, medical equipments and diagnostic reagents. From R&D to production and the marketing promotion of products.
We have maintained good business relationship with more than 100 biotechnology companies and customers both domestic and abroad.Our key domestic account including Nanjing University, Wuhan Institute of Virology CAS, etc. And our answering product --disposable collectors (saliva) have been exported to Hong Kong, Southeast Asia, Australia and North America.